Skip to main content
. Author manuscript; available in PMC: 2024 Mar 25.
Published in final edited form as: Cancer Causes Control. 2023 Nov 27;35(4):661–669. doi: 10.1007/s10552-023-01822-8

Table 4.

Hazard ratios and 95% confidence intervals for candidate CpGs from literature and liver cancer, in the Strong Heart Study

CpG site Model 1
Model 2
HR (95% CI) p-value* HR (95% CI) p-value
cg00300879 1.12 (0.72, 1.76) 0.37 1.12 (0.70, 1.77) 0.64
cg26764761 1.07 (0.68, 1.67) 0.79 1.03 (0.67, 1.61) 0.87
cg10864200 1.50 (0.89, 2.52) 0.06 1.51 (0.90, 2.52) 0.12
cg15414745 1.15 (0.72, 1.85) 0.71 1.13 (0.69, 1.84) 0.66
cg07080864 0.89 (0.57, 1.38) 0.73 0.87 (0.55, 1.36) 0.54
cg15079934 1.95 (1.11, 3.43) 0.03 1.93 (1.1, 3.39) 0.02
cg24049493 0.94 (0.59, 1.49) 0.73 0.90 (0.56, 1.45) 0.62

The HR is reported per SD of Beta for candidate CpGs

Model 1: age, sex, center, and immune cell proportions

Model 2: Model 1 + alcohol (never, ever, current), smoking (never, ever, current), BMI and LDL-cholesterol